METHYL 2-(5-HYDROXYPYRIMIDIN-2-YL)ACETATE, 95.0%, 250mg

p-coumaric acid, min. 98%, 50 g, glass packaging

(S)-3-((3,3-Dimethylbutyl)amino)-4-(((S)-1-methoxy-1-oxo-3-phenylpropan-2-yl)amino)-4-oxobutanoic acid, 95.0%, 1kg

(4-Methylpyridin-2-yl)boronic acid, 95.0%, 5g

1-(4-Cyclopropylphenyl)ethanone, 95.0%, 10g

METHYL 5-AMINO-2-METHYLISONICOTINATE, 95.0%, 500mg

4,6-Dihydroxy-2-methylpyrimidine>96.0%(T)5g

2-Methyl-6-(trifluoromethyl)pyridine-3-carbonylchloride, 10g

4-[(4-methylpiperidin-1-yl)sulfonyl]benzoic acid, 95.0%, 1g

4-(4-Nitrophenyl)morpholine>98.0%(GC)(T)25g

(2,6-Dichlorophenyl)acetaldehyde, 97.0%, 5g

2-(4-(2-Methylpyridin-4-yl)phenyl)-N-(4-(pyridin-3-yl)phenyl)acetamide, 95.0%, 100mg

2-Methyl-10H-benzo[b]thieno[2,3-e][1,4]diazepin-4-amine hydrochloride, 95.0%, 25g